SARS CoV 2 News and Research

RSS

Study identifies a host of agents with anti-SARS-CoV-2 potential

A team of researchers at the Genomics Research Center, Academia Sinica, in Taiwan, evaluated the efficacy of 2,855 agents against SARS-CoV-2.

22 Jan 2021

A traditional Chinese medicine could help treat COVID‐19 symptoms

A team of researchers in China – at Guangzhou University of Chinese Medicine and Yunnan University of Chinese Medicine – recently explored the therapeutic properties of Yinqiao powder in treating COVID-19 symptoms. Their findings were recently published in Phytotherapy Research.

22 Jan 2021

Accurate quantitative COVID-19 antibody test kit by EKF

EKF Diagnostics, the global in vitro diagnostics company, announces that it has introduced one of the first tests to precisely measure levels of COVID-19 neutralizing antibodies in individuals.

From EKF Diagnostics 22 Jan 2021

EKF opens larger facility to increase production of key component for COVID-19 testing regime

EKF’s new facilities in Llandough, Cardiff, for the manufacture of PrimeStore® MTM viral transport media, enabling pathogenic samples to be collected and transported safely and easily in compliance with UN3373 packaging regulations.

From EKF Diagnostics 22 Jan 2021

Study highlights link between obesity, impaired metabolic health, and COVID-19 severity

In a Nature Reviews Endocrinology article authors from the German Center for Diabetes Research (DZD) highlight the interconnection of obesity and impaired metabolic health with the severity of COVID-19.

22 Jan 2021

Vaccinating people over 60 is the most effective way to mitigate COVID-19 mortality

Vaccinating people over 60 is the most effective way to mitigate mortality from COVID-19, a new age-based modeling study suggests.

22 Jan 2021

Infusion of convalescent blood plasma benefits patient with severe COVID-19

A 72-year-old woman was hospitalized with severe COVID-19 disease, 33 days after the onset of symptoms.

22 Jan 2021

People with severe COVID-19 cases may have more protective "memory" T cells

A big question on people's minds these days: how long does immunity to SARS-CoV-2 last following infection?

22 Jan 2021

New model shows key role of innate immunity in controlling COVID-19 viral load

Since SARS-CoV-2 was identified in December 2019, researchers have worked feverishly to study the novel coronavirus. Although much knowledge has been gained, scientists still have a lot to learn about how SARS-CoV-2 interacts with the human body, and how the immune system fights it.

21 Jan 2021

New data on impact of spike mutations and B117 UK variant on neutralization by mAbs and sera

A recent paper by British and Dutch scientists, currently available on the bioRxiv* preprint server, shows that the neutralizing activity of monoclonal antibodies can be dramatically reduced by mutations of the SARS-CoV-2 spike glycoprotein – unlike polyclonal antibodies generated after natural infection that remain active regardless of any introduced amino acid changes.

21 Jan 2021

SARS-CoV-2 variants appear to arise independently of local transmission

Researchers at the University of Michigan in the United States have cautioned against only using within-host minor genetic variations to resolve the genomic epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

21 Jan 2021

Pfizer-BioNTech vaccine shows reduced neutralization potential against SARS-CoV-2 B.1.1.7 spike variant

Researchers in the UK have conducted a study assessing the efficacy of the Pfizer-BioNTech COVID-19 vaccine BNT162b2 against the new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

21 Jan 2021

Positive messages could potentially increase mask usage during the pandemic

Many organizations are looking at effective ways to communicate the importance of wearing a mask, especially as highly transmissible new strains of coronavirus threaten to cause a surge in infections.

21 Jan 2021

Randomized trials could help clarify uncertainties around reopening schools safely

Schools are closing again in response to surging levels of COVID-19 infection, but staging randomised trials when students eventually return could help to clarify uncertainties around when we should send children back to the classroom, according to a new study.

21 Jan 2021

SARS CoV 2 News and Research

Study identifies a host of agents with anti-SARS-CoV-2 potential

A traditional Chinese medicine could help treat COVID‐19 symptoms

Accurate quantitative COVID-19 antibody test kit by EKF

EKF opens larger facility to increase production of key component for COVID-19 testing regime

Study highlights link between obesity, impaired metabolic health, and COVID-19 severity

Vaccinating people over 60 is the most effective way to mitigate COVID-19 mortality

Infusion of convalescent blood plasma benefits patient with severe COVID-19

People with severe COVID-19 cases may have more protective "memory" T cells

New model shows key role of innate immunity in controlling COVID-19 viral load

New data on impact of spike mutations and B117 UK variant on neutralization by mAbs and sera

SARS-CoV-2 variants appear to arise independently of local transmission

Pfizer-BioNTech vaccine shows reduced neutralization potential against SARS-CoV-2 B.1.1.7 spike variant

Positive messages could potentially increase mask usage during the pandemic

Randomized trials could help clarify uncertainties around reopening schools safely

SARS-CoV-2 suppresses host innate immunity

Scientists identify a molecular mechanism that protects the fetus from maternal infection

Researchers use SARS-CoV-2 to bioengineer universal vaccine platform

New SARS-CoV-2 strain detected in Southern California, USA

Vitamin D deficiency associated with higher risk of COVID-19 hospitalization

High factor V levels linked to lymphopenia and weakened immunity in severe COVID-19

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News